# Bridge to Orthotopic Liver Transplantation (OLT) - Surefire Precision vs Endhole Embolization With DEBTACE

> **NCT03170869** · NA · TERMINATED · sponsor: **University of Colorado, Denver** · enrollment: 11 (actual)

## Conditions studied

- Hepatocellular Carcinoma of the Liver
- Subjects Eligible for Liver Transplantation

## Interventions

- **DEVICE:** Surefire Precision Infusion System

## Key facts

- **NCT ID:** NCT03170869
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-04-12
- **Primary completion:** 2018-09-11
- **Final completion:** 2018-09-11
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Sponsor withdrew funding
- **Last updated:** 2022-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03170869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03170869, "Bridge to Orthotopic Liver Transplantation (OLT) - Surefire Precision vs Endhole Embolization With DEBTACE". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03170869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*